News

Events

Cygnal Therapeutics Expands Leadership Team with Appointment of John A. Wagner, M.D., Ph.D., as Chief Medical Officer

09.16.2020 PRNewsWire

Cygnal Therapeutics to Present at the 2020 Wells Fargo Virtual Healthcare Conference

09.04.2020 PRNewsWire

Dr. Pearl Huang: Pushing the Boundaries of Science

07.01.2020 PharmaVoice

Cygnal Therapeutics Leader and Scientific Advisory Board Members Co-Author Paper in Cell Alongside Cancer Science Experts

04.17.2020 PRNewsWire

Roadmap for the Emerging Field of Cancer Neuroscience

04.16.2020 Cell

Cancer–neuronal crosstalk and the startups working to silence it

02.07.2020 Nature Biotechnology

Cygnal Therapeutics Announces Scientific Advisory Board

01.31.2020 PRNewsWire

Cygnal Appoints Elaine Caughey as Chief Business Officer

12.19.2019 PRNewsWire

'We're ripe': Cygnal draws the curtain on Flagship's latest bet on exoneural biology — and $65M in cash

10.08.2019 Endpoints

Cygnal Therapeutics emerges from ‘stealth mode’ with $65m in venture capital

10.08.2019 Boston Globe

Flagship unveils Cygnal, a nervy take on cancer, inflammation

10.08.2019 BioCentury

Flagship Pioneering Unveils Cygnal Therapeutics

10.08.2019 PRNewsWire

Keystone Symposia: Tissue Immunity, Jan. 26-29, 2020

01.27.2020 Exhibitor

Cell Symposia. Hallmark of Cancer, Nov. 17-19, 2019

11.07.2019 Exhibitor

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Oct. 26-30, 2019

10.28.2019 Exhibitor

FierceBiotech 4th Drug Development Forum, October 28-29, 2019

08.05.2019 Speaker